Skip to main content
. 2021 Jun 18;36(2):138–145. doi: 10.5222/MMJ.2021.84666

Table 2.

Correlation of parametric data with each other.

Character Gender Size Side Localization Margin features Extansion Perineural spread Lymph-adenopathy Enhancement pattern
Character(r) 1 -,032 ,140 ,084 ,247 ,622** -,678** -,502** -,490** -,146
Gender(r) -,032 1 -,283 ,149 -,323* -,227 -,059 -,133 ,053 -,010
Size(r) ,140 -,283 1 ,066 ,604** ,253 -,322* -,036 -,452** -,185
Side(r) ,084 ,149 ,066 1 -,040 ,128 -,153 -,064 -,201 -,048
Localization(r) ,247 -,323* ,604** -,040 1 ,354** -,340* -,232 -,291* ,095
Margin features(r) ,622** -,227 ,253 ,128 ,354** 1 -,624** -,471** -,445** -,104
Extansion(r) -,678** -,059 -,322* -,153 -,340* -,624** 1 ,443** ,632** ,000
Perineural spread(r) -,502** -,133 -,036 -,064 -,232 -,471** ,443** 1 ,125 ,238
Lymphadenopathy(r) -,490** ,053 -,452** -,201 -,291* -,445** ,632** ,125 1 ,000
Enhancement pattern(r) -,146 -,010 -,185 -,048 ,095 -,104 ,000 ,238 ,000 1

Character; malignant-benign, **Correlation Significant at p<0.01 level, *Correlation Significant at p <0.05 level, r; Pearson Correlation coefficient.